X
AGL icon

Xponance’s Agilon Health AGL Stock Holding History

Xponance’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-971
Closed -$16.7K – 1688
2025
Q4 		$16.7K Buy
971
+12
+1% +$233 ﹤0.01% 1562
2025
Q3 		$24.7K Buy
959
+12
+1% +$453 ﹤0.01% 1517
2025
Q2 		$54.5K Buy
947
+1
+0.1% +$80 ﹤0.01% 1455
2025
Q1 		$102K Buy
946
+67
+8% +$5.83K ﹤0.01% 1345
2024
Q4 		$41.8K Buy
879
+63
+8% +$3.81K ﹤0.01% 1407
2024
Q3 		$80.1K Buy
816
+15
+2% +$1.94K ﹤0.01% 1335
2024
Q2 		$131K Sell
801
-547
-41% -$77.9K ﹤0.01% 1224
2024
Q1 		$206K Sell
1,348
-87
-6% -$14.5K ﹤0.01% 1190
2023
Q4 		$450K Sell
1,435
-72
-5% -$26.1K 0.01% 966
2023
Q3 		$669K Buy
1,507
+105
+7% +$47.4K 0.01% 784
2023
Q2 		$608K Buy
1,402
+441
+46% +$248K 0.01% 828
2023
Q1 		$571K Buy
961
+1
+0.1% +$560 0.01% 875
2022
Q4 		$388K Buy
960
+100
+12% +$46.9K 0.01% 974
2022
Q3 		$504K Buy
860
+31
+4% +$18.6K 0.01% 841
2022
Q2 		$453K Buy
829
+116
+16% +$58.7K 0.01% 891
2022
Q1 		$452K Sell
713
-16
-2% -$8.25K 0.01% 929
2021
Q4 		$492K Buy
+729
New +$444K 0.01% 904
2021
Q3 		– Sell
-218
Closed -$221K – 1174
2021
Q2 		$221K Buy
+218
New +$191K ﹤0.01% 1148

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Xponance's AGL Position: Q1 2026 in Review

Xponance sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 971 shares — an estimated $16.7K sold.

Xponance first reported a position in AGL in Q2 2021 and held it in 18 quarters. The position peaked at $669K in Q3 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Xponance reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Xponance sold 971 Agilon Health shares in Q1 2026, an estimated $16.7K.
  • Xponance first reported a position in Agilon Health in Q2 2021 and held it in 18 quarters.
  • Xponance's Agilon Health position peaked at $669K in Q3 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.